Research & Development

秋霞网在线伦理免费每日在线av免费视频超碰在线联合国粮农组织举行总干事交接仪式 屈冬玉到任


  “不是,我能跑到那里去?”   阿嬌笑道︰“你家在涼州的產業我也感興趣,如果出讓我會接下來。”秋霞网在线伦理免费   人群中的周鴻仰天大笑一聲道︰“雲瑯,皇帝無道,我們共誅之。”每日在线av免费视频   劉徹淡淡的道︰“他們既然進了角斗場,那麼,他們的生命不過是供人娛樂的物件而已,在角斗場要公平,豈不是天下最大的笑話?”   雲瑯搖頭道︰“身毒國從來就不會出什麼猛士,否則也不會被異族人隨意入侵了。所以,微臣認為大秦國身經百戰的猛士會贏。”超碰在线   此詩一出,劉徹震驚的魂不附體,敬阿嬌為天人!

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo